LONDON (Reuters) - The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness.br clear='all'/br/br/a href="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/1/rc.htm" rel="nofollow"img src="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/1/rc.img" border="0"//abr/br/a href="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/2/rc.htm" rel="nofollow"img src="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/2/rc.img" border="0"//abr/br/a href="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/3/rc.htm" rel="nofollow"img src="http://rc.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/rc/3/rc.img" border="0"//abr/br/a href="http://da.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/a2.htm"img src="http://da.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/a2.img" border="0"//abr/a href="http://adchoice.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/ach.htm"img src="http://adchoice.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/ach.img" border="0"//aimg width="1" height="1" src="http://pi.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/a2t.img" border="0"/img width="1" height="1" src="http://pi2.feedsportal.com/r/238386436784/u/49/f/654220/c/35217/s/4a3ccbe1/sc/32/a2t2.img" border="0"/img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654220/s/4a3ccbe1/sc/32/mf.gif' border='0'/div class="feedflare"
a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=_zSdXYP4MKI:ZjrDEutIhSc:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=_zSdXYP4MKI:ZjrDEutIhSc:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=_zSdXYP4MKI:ZjrDEutIhSc:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=_zSdXYP4MKI:ZjrDEutIhSc:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=_zSdXYP4MKI:ZjrDEutIhSc:V_sGLiPBpWU" border="0"/img/a
/divimg src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/_zSdXYP4MKI" height="1" width="1" alt=""/
